Rba Wealth Management, LLC Amgen Inc Transaction History

Rba Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $188,920 - $221,343	-890 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $233 - $259	-1 Reduced 0.11%	890 $217,000
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $197,721 - $230,412	891 New	891 $221,000
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $211,836 - $252,258	-979 Closed	0 $0
Q2 2020 Sep 29, 2020	BUY	$197.81 - $242.74 $193,655 - $237,642	979 New	979 $231,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $200,464 - $265,870	-1,100 Closed	0 $0
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $946 - $1,216	-5 Reduced 0.45%	1,100 $264,000
Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $8,705 - $10,431	-50 Reduced 4.33%	1,105 $214,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $21,671 - $25,403	-130 Reduced 10.12%	1,155 $213,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $232,417 - $261,985	1,285 New	1,285 $249,000

3,119

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Rba Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rba Wealth Management, LLC with notifications on news.